论文部分内容阅读
目的分析并探讨应用低分子肝素钙治疗不稳定型心绞痛的治疗效果。方法将2008-12-2010-12期间入院治疗的76例不稳定型心绞痛患者随机分为治疗组与对照组各38例,对照组采用常规治疗方法,治疗组在常规治疗基础上联合使用低分子量肝素钙,疗程为1周。结果治疗组总有效率达94.7%(36/38),而对照组总有效率为73.7%(28/38),两组比较差异有统计学意义(P<0.05)。76例患者均未出现明显的不良反应发生,患者凝血四项检查结果均在正常范围内。结论低分子肝素钙治疗不稳定型心绞痛可显著改善心绞痛患者的心肌缺血症状,方法简单,疗效可靠,具有广阔的临床价值。
Objective To analyze and discuss the therapeutic effect of low molecular weight heparin on unstable angina pectoris. Methods A total of 76 patients with unstable angina pectoris who were hospitalized during 2008-12-2010-12 were randomly divided into treatment group (38 cases) and control group (38 cases). The control group was treated by conventional method. The treatment group was treated with low molecular weight Heparin calcium, treatment for 1 week. Results The total effective rate of the treatment group was 94.7% (36/38), while the total effective rate of the control group was 73.7% (28/38). The difference between the two groups was statistically significant (P <0.05). No significant adverse reactions occurred in 76 patients. The results of the four tests of coagulation in patients were within the normal range. Conclusion Low molecular weight heparin treatment of unstable angina can significantly improve myocardial ischemia in patients with angina pectoris, the method is simple, reliable, and has broad clinical value.